Mia Aggergaard Langbøl

Short presentation

My research is investigating whether handling of oxidative stress in the human body varies depending on whether a person suffers from glaucoma or not. The hypothesis is that glaucoma patients have a decreased ability to regulate the oxygen and energy that is metabolized in the body. This can cause damage to lipids and metabolites. The retina is especially sensitive towards such damage which is why we assume that the consequences are essential risk factors in the development of glaucoma. We use a human experimental hypoxia model to test how a fluctuating oxygen supply affects phenotypes with and without glaucoma. 

Primary fields of research

Oxidative stress, inflammation and vascular regulation in the retina.

Current research

• Regulation of retinal vessel diameters in glaucoma
• Systemic levels of oxidative stress and antioxidant molecules in glaucoma
• Inflammatory biomarkers in glaucoma
• Metabolomics in glaucoma
• Lipidomics in glaucoma

CV

Academic degrees

2018-ongoing: PhD in health sciences, Eye Translational Research Unit, Department of Drug Design and Pharmacology, University of copenhagen

2018: MsC in Biochemistry, University of copenhagen

2016: BsC in Biochemistry, University of copenhagen

Employments

2018-ongoing: PhD Fellow, Eye Translational Research Unit, Department of Drug Design and Pharmacology, University of copenhagen

Funding

2019: Synoptikfoundation

2018: Department of Drug Design and Pharmacology

2018: Eye Foundation

2018: Jørgen Bagenkop Nielsens Myopi-foundation

Short presentation

Academic degrees:

2018-ongoing: PhD Fellow, Eye Translational Research Unit, Department of Drug Design and Pharmacology, University of Copenhagen

2018: MsC in Biochemistry, University of Copenhagen

2016: BsC in Biochemistry, University of Copenhagen

Employments

2018-ongoing: PhD Fellow, Eye Translational Research Unit, Department of Drug Design and Pharmacology, University of Copenhagen

Funding

2019: Synoptikfonden

2018: Department of Drug Design and Pharmacology

2018: Øjenforeningen

2018: Jørgen Bagenkop Nielsens Myopi Fond